✦ LIBER ✦

Acute Spontaneous Tumor-Lysis Syndrome in a Pregnant Woman with Non-Hodgkin’s Lymphoma

✍ Scribed by Mohamed Riad El-Sonbaty; Zouheir Bitar; Adel Abdulrazak

Publisher: Carden Jennings Publishing
Year: 2001
Tongue: English
Weight: 115 KB
Volume: 73
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02981967

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute tumor lysis syndrome in non-Hodgki

Acute tumor lysis syndrome in non-Hodgkin lymphoma induced by dexamethasone

✍ Kapil Dhingra; Dr. Samuel R. Newcom 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Acute renal failure due to tumor lysis s

Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin’s lymphoma

✍ Asterios Karagiannis; Ioannis Tsorlalis; Anna Kakafika; Panagiotis Pateinakis; V 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 146 KB

Multiple recurrences of acute tumor lysi

Multiple recurrences of acute tumor lysis syndrome in an indolent non-hodgkin's lymphoma

✍ Ralph V. Boccia; Dan L. Longo; Michael L. Lieber; Elaine S. Jaffe; Richard I. Fi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

Increasing recognition of corticosteroid

Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma

✍ Joseph Sparano; Mark Ramirez; Peter H. Wiernik 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

Spontaneous tumor lysis syndrome in a pa

Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome

✍ Abdurrahman Tufan; Nese Unal; Ebru Koca; Ibrahim Onal; Salih Aksu; Ibrahim Hazne 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 55 KB

Tumor lysis syndrome occurring after the

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re